BRAND_ANALYSIS#MODERNAHEALTH & PHARMA#19 OF 26 IN HEALTH & PHARMAALIGNED
Moderna
· Public · Updated 09 Apr 2026 08:47 UTC
#716 of 1208 overall by tension · #19 of 26 in Health & Pharma
12Aligned
The Balanced
Analysis
Moderna's collapse (C=46 but B=34, -6.53% stock, 0.20 sentiment) is instructive: pandemic-era relevance doesn't survive the pandemic. The company that rode hype to IPO is now riding hype downward.
IN THE NEWS (60 articles this week)
Moderna to pay $950M to settle vaccine litigation with Arbutus, Genevant - FirstWord Pharma
Top Moderna Shareholders - Investopedia
Dr. Fauci: "At this point, there is no need for a variant-specific booster" - C-SPAN